Contour ProtégéAI

Oncology Radiology

Regulatory Status Disclosed

Overview

Contour ProtégéAI by MIM Software is an advanced AI auto-contouring solution designed for medical imaging, primarily within Radiation Oncology. It leverages machine learning algorithms to automatically segment anatomical structures and organs at risk (OARs) on CT and MR images. This tool aims to significantly enhance the efficiency and accuracy of radiation therapy treatment planning by reducing the time-consuming manual contouring process. It supports flexible deployment options, including both cloud-hosted and local installations, and integrates seamlessly into existing clinical workflows. Recent updates, such as Contour ProtégéAI+, introduce zero-click auto-contouring capabilities for structures like lymph nodes, further streamlining the planning process.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Next-generation segmentation utilizing deep learning algorithms
  • Auto-segmentation begins immediately upon image reception
  • Powered by MIMapp Catalystu2122 cloud-based platform
  • No additional hardware required for deployment
  • Pre-trained models, no need for user-contoured datasets
  • Quick to deploy and scale for high patient volumes
  • Supports both cloud-hosted and local deployment options
  • Zero-click AI auto-contouring for specific structures (Contour ProtégéAI+)
  • Generates head & neck and breast lymph node level structures, and OARs
  • Results exported directly to Treatment Planning Systems (TPS) or MIM software

Use Cases

  • Radiation oncology treatment planning and segmentation
  • Enhancements for Molecular Radiotherapy (MRT)
  • Aiding adaptive radiation therapy
  • Transferring contours to radiation therapy treatment planning systems
  • Archiving contours for patient follow-up and management
  • Quantitative analysis of anatomical structures

What Physicians Need to Know

Key Capabilities
Contour ProtégéAI utilizes deep learning to automate the delineation of organs-at-risk (OARs) in radiation oncology. It offers next-generation segmentation with deep learning algorithms and initiates auto-segmentation immediately upon receiving simulation images. The software supports automated processing of CT and MR images. The latest version, Contour ProtégéAI+ 2.0, includes new models such as an MR Brain model and an updated CT Male Pelvis model.
Clinical Utility
The primary purpose of Contour ProtégéAI is to reduce the workload of radiation oncologists by automating OAR delineation, aiming to increase efficiency while maintaining clinical quality. It has been validated for use in complex head and neck cancer, demonstrating accurate delineation of OARs on CT images without user intervention and significantly reducing segmentation time compared to manual contouring. The tool helps streamline radiation therapy planning, allowing care teams to focus on refining treatment plans.
Integration Options
Contour ProtégéAI is designed to integrate seamlessly into existing clinical workflows. It can be rapidly implemented into virtually any environment via local deployment or deployed on a remote server using the MIMcloud service for data management and transfer. Results can be exported directly into treatment planning systems or MIM Workflows™.
Compliance Status
Contour ProtégéAI has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The FDA clearance for Contour ProtégéAI+ 2.0 includes a Predetermined Change Control Plan (PCCP) to enable future model updates and expansion. It is classified under regulation number 892.205023. The software has also received approval from Health Canada.
Pricing Model
MIM Software utilizes a subscription-based enterprise licensing model. Pricing is not publicly disclosed; interested parties need to contact the vendor for a quote based on deployment needs.
User Experience
Contour ProtégéAI is designed for minimal user interaction, initiating contouring automatically. It aims to provide a zero-click auto-contouring experience. User feedback has been a key driver in product development and quality improvements.
Support Quality
MIM Software offers various support resources, including a Knowledge Center with training videos and FAQs. Users can schedule one-on-one support with Contour ProtégéAI+ Specialists for non-urgent assistance, workflow customizations, and troubleshooting.
Implementation Complexity
Contour ProtégéAI can be rapidly implemented into virtually any environment via local deployment. It is designed to integrate seamlessly into existing clinical workflows with minimal effort.
Evidence Base
The AI models for Contour ProtégéAI+ were developed and validated using multi-institution datasets. Studies have shown that high-contrast structures like the bladder and femoral heads exhibit high reliability, while irregular shapes may require rigorous manual review. Research validation results indicate that auto-contouring with observer editing saves significant time while maintaining quality. A study evaluating Contour ProtégéAI (version 4.0) across head and neck, prostate, and lung patients showed good agreement between AI-generated contours and expert contours for 75% of the OARs.
Physician Tip

While Contour ProtégéAI significantly automates OAR delineation, physicians should remain vigilant, especially with small or irregular structures like the bowel and sigmoid colon, which may require structured manual review. The tool shifts the physician's role from creator to validator, emphasizing the importance of detecting automation errors and maintaining departmental quality assurance. For high-contrast structures such as the bladder, prostate, sacrum, and femoral heads, a high level of trust in auto-contouring results is generally warranted.

Contour ProtégéAI is designed for seamless integration into existing clinical workflows and can export results directly to treatment planning systems or MIM Workflows™. It supports both cloud-hosted (MIMcloud) and local deployment, offering flexibility for various departmental setups.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentOn-premise, Cloud (MIMcloud™)
Mobile AppMobile MIM™, VueMe™
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Radiology

FDA clearance history

Each FDA authorization for this product and its earlier versions, newest first. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-02-03K250035 510(k)Contour ProtégéAI+
2023-11-08K231765 510(k)Contour ProtégéAI

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Contour ProtégéAI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Contour ProtégéAI.

Loading videos...

View all on YouTube

Frequently Asked Questions

Contour ProtégéAI is an AI-powered auto-contouring software developed by MIM Software Inc. that assists in radiation oncology treatment planning. It uses deep learning algorithms to automatically delineate organs-at-risk (OARs) and lymph node levels on medical images, primarily CT and MR scans. This automation aims to reduce the time physicians spend on manual contouring, allowing them to focus on evaluating treatment options and refining patient-specific plans.
Contour ProtégéAI+ 2.0 has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which includes a Predetermined Change Control Plan (PCCP) to allow for future model updates and enhancements without requiring additional regulatory reviews. As a medical device, its use must comply with FDA regulations, including registration, labeling, medical device reporting, and good manufacturing practices. It is intended to be used by trained medical professionals as a tool to assist in the automated processing of digital medical images, with the understanding that appropriate image visualization software must be used to review and, if necessary, edit the automatically generated results.
While Contour ProtégéAI aims for accuracy, studies suggest that high-contrast structures like the bladder, prostate, sacrum, and femoral heads show high reliability with AI auto-contouring. However, small or irregular shapes such as the bowel and sigmoid colon may score significantly lower and require rigorous manual review or full manual contouring. It's crucial for physicians to validate all AI-generated structures before clinical use, as the AI transition shifts the physician's role from creator to validator, requiring new clinical judgment skills to detect subtle automation errors.
Contour ProtégéAI is designed to offer improved efficiency and accuracy compared to traditional manual contouring, which is a time-consuming task in radiation oncology. Studies have shown that AI-based solutions generally reduce time requirements and the need for modifications compared to previous atlas-based methods. However, comparisons with other AI tools, such as OncoStudio, have shown varying performance, with some population-specific tools outperforming globally developed tools like Protégé AI in certain anatomical regions.
MIM Software does not publicly disclose pricing for Contour ProtégéAI. However, an AI tool that drafts normal-structure contours is considered a practice expense item, not a separately reportable procedure, under the fee schedule logic. Existing CPT codes for clinical treatment planning and dosimetry plans already cover contouring as part of the physician's work. Therefore, the business case for AI contouring in 2026 is primarily based on increased throughput and efficiency, rather than a new reimbursement code.
Contour ProtégéAI is designed for seamless integration into existing clinical workflows and can export results directly into various treatment planning systems (TPS) or MIM Workflows. It operates with minimal user intervention, initiating auto-contouring automatically when a patient is simulated, and the contours are ready for review in the TPS or MIM Maestro.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-10 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.